Many women at high risk for breast or ovarian cancer are choosing to undergo surgery as a precautionary measure to decrease their cancer risk, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

BBC News says that a "flawed gene" has been linked to ovarian cancer. The website says that, by looking at the DNA of 17,000 women, scientists have identified a genetic flaw that can increase the risk of the cancer.

A new partnership between Clark Atlanta University and Georgia Tech will explore ways to use DNA sequencing to analyze the genetic makeup of cancer patients and develop customized care.

Treatment with "suicide" genes slowed ovarian tumor growth in mice and may one day offer a way to treat late-stage ovarian cancer in women, U.S. scientists say.

Our Stocks to Watch today include Access Pharmaceuticals Inc. , Metatron Inc. , Applied DNA Sciences Inc.

Published: Monday, August 3, 2009 at 5:11 a.m. Last Modified: Monday, August 3, 2009 at 5:11 a.m. Not long ago, at a meeting of an advisory group established by Congress to monitor the war on cancer, participants were asked how to speed progress.

Scientists have discovered a common genetic difference in women at risk from ovarian cancer , in an important development they say could save lives.

Craig Broeder is a man on a mission and he isn't letting a few severe thunderstorms, gusting wind and tornado warnings stop him from completing a 9,000-mile bike ride around the United States.

Tiny particles carrying a killer gene can effectively suppress ovarian tumor growth in mice, according to a team of researchers from MIT and the Lankenau Institute.

Like most married men, Dr. Craig Broeder wanted to do something special for his wife's anniversary.

Treatment with "suicide" genes slowed ovarian tumor growth in mice and may one day offer a way to treat late-stage ovarian cancer in women, U.S. scientists say.

Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.

A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial antitumor activity in ovarian cancer cell lines and in mice, according to a study published online July 29 in the Journal of the National Cancer Institute.

Women who have taken hormone therapy are at a higher risk of developing ovarian cancer than women who have not, according to a nationwide study involving nearly 910,000 women in Denmark.

CytRx Corporation , a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that results demonstrating that its cancer drug candidate INNO-206 caused statistically significant tumor shrinkage in an animal model of ovarian cancer have been accepted for publication in the ...

Tiny ovarian tumors lurk in the Fallopian tubes for an average of four years before they grow large enough to be detected, researchers reported on Monday in a study that explains why diagnosis usually comes too late to save a woman's life.

Marilyn B. Gula Mountains of Hope Foundation donates $50,000 for TGen's advance-stage breast cancer research TGen researcher named to Medical Advisory Board of Gula Foundation; Laboratory research bench at TGen named in memory of cancer fighter 07-15-2009 PHOENIX, Ariz.

Women whose menstrual periods start at a young age are less likely to survive ovarian cancer than their peers whose periods start later, new research shows.

A new ovarian cancer drug called Nanotax will undergo Phase 1 clinical trials in Wichita.

AMHERST Evelyn Rushton knows all too well about ovarian cancer. In January 2002, Rushton was diagnosed with the disease that kills 1,500 Canadians each year.